ClinicalTrials.Veeva

Menu

Non-responders to Antiplatelet Treatment in Acute Ischaemic Stroke) (NATIS)

Z

Zealand University Hospital

Status

Completed

Conditions

Acute Ischemic Stroke

Treatments

Other: blood sampling for HOTPR-testing

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Determination of frequency of Clopidigrel- and Acetacylicacid-non-responders (HOTPR) in acute ischemic stroke patients.

Full description

Determination of frequency of Clopidigrel- and Acetacylicacid-non-responders (HOTPR) in acute ischemic stroke patients using the VerifyNow system.

Enrollment

496 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Suspected acute ischemic stroke and loading dose of Clopidogrel or Acetacylicacid

Exclusion criteria

  • Previous treatment with platelet inhibitor
  • NOAC or Vitamin K-antagonist treatment
  • Final diagnosis other than Ischemoc stroke or Transitoric ischemic attack

Trial design

496 participants in 2 patient groups

Clopidogrel
Description:
Clopidogrel non-responders (HOTPR) Blood sampling for HOTPR-testing
Treatment:
Other: blood sampling for HOTPR-testing
Acetacylicacid
Description:
Acetcylicacid non-responders (HOTPR), Blood sampling for HOTPR-testing
Treatment:
Other: blood sampling for HOTPR-testing

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems